Valeant CEO Obstructing Drug Price Probe, Lawmaker Says
Valeant Pharmaceuticals International Inc.'s outgoing CEO has been obstructing a congressional inquiry into the company's drug pricing and relationship with Philidor Rx Services LLC by refusing to hand over documents, a...To view the full article, register now.
Already a subscriber? Click here to view full article